article thumbnail

SAEM Clinical Images Series: A Blistery Mystery

ALiEM - Pharm Pearls

Immune thrombocytopenia (ITP) is an acquired autoimmune disorder caused by autoantibodies against platelet antigens. Case Discussion Take-Home Points Immune thrombocytopenia is an acquired isolated thrombocytopenia that can be a primary disorder or secondary to viral illness, autoimmune syndrome, or immunodeficiency disease.

Immunity 152
article thumbnail

Health Innovators: PureTech Health’s Daphne Zohar

pharmaphorum

They discuss the publicly-listed biotech’s pipeline projects and focus on the BIG (brain-immune-gut) axis as well as PureTech’s interest in digital therapeutics. Prior to this, he founded pharmaphorum in 2009, which was acquired by Healthware Group in June 2020.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Low Dose Naltrexone and Hashimoto’s

The Thyroid Pharmacist

However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. These include Crohn’s, MS, and Hashimoto’s, as well as other immune system-related conditions such as cancer and HIV/AIDS. Doses of 1.5-4.5

article thumbnail

Engineering scalable iPSC-NK therapies

European Pharmaceutical Review

billion by 2030, driven by the rising demand for off-the-shelf therapies that offer scalable, standardised solutions for treating a wide range of diseases, including cancer and auto-immune diseases. Cancer Immunity and Immunotherapy. The global cell therapy market is projected to reach $20.07 Internet] Grand View Research. Thangaraj J.

article thumbnail

Using alkali-metal cation recognition of ?-cyclodextrin to detect lithium ions by MALDI-TOF

European Pharmaceutical Review

Johan’s PhD studies at the University of Gothenburg were focused on food and allergy, and the effect of fatty acids on immune cells. Characterization of natural wax esters by MALDI-TOF mass spectrometry, J Mass Spectrom , 2009, 44, 101–110. An overview, J Incl Phenom Macrocycl Chem , 2009, 65, 237-248. Tran A, Monreal IA, et al.

article thumbnail

NICE methods and process review aims to create fertile ground for innovation

pharmaphorum

We are even at a point where some cancer medicines are created for each individual patient using their own immune system. Another promising proposed change in the methods review is a move to replace the end-of-life modifier, introduced in 2009 as a way to provide greater access to life-lengthening drugs, with a severity modifier.

article thumbnail

Things to Know About the INBDE Dental Board Exam

Board Vitals - Pharmacist

Cellular and molecular bases of immune and non-immune host defense mechanisms: 9.0% These areas of fundamental knowledge are further divided among the following INBDE subject areas : Molecular, biochemical, cellular, and systems-level development, structure, and function: 12.2% Pharmacology: 10.6% How much does the INBDE cost ?